Hepatocellular carcinoma after non-A, non-B posttransfusion hepatitis - PubMed (original) (raw)
Case Reports
. 1984 Oct;79(10):777-81.
- PMID: 6091443
Case Reports
Hepatocellular carcinoma after non-A, non-B posttransfusion hepatitis
K Kiyosawa et al. Am J Gastroenterol. 1984 Oct.
Abstract
A case is reported in which non-A, non-B posttransfusion hepatitis was followed serially by chronic persistent hepatitis, chronic active hepatitis, and liver cirrhosis that finally developed into hepatocellular carcinoma. The patient died after a 19-year clinical course. During the last 8 years, repeated attempts to identify serum hepatitis B surface antigen, antibody to hepatitis B surface antigen, and antibody to hepatitis B core antigen were consistently negative. Liver biopsy was performed five times during the clinical course, and at autopsy, liver tissue was obtained from four different nontumor regions. These specimens were investigated by a peroxidase immunoenzyme method which failed to detect hepatitis B surface antigen and hepatitis B core antigen. Non-A, non-B posttransfusion hepatitis may become chronic and sometimes may advance to hepatocellular carcinoma.
Similar articles
- Comparative analysis of HBV and HCV infection in hepatocellular carcinoma and chronic liver disease--an autopsy based study.
Vaiphei K, Pal NS, Arora SK. Vaiphei K, et al. Indian J Pathol Microbiol. 2006 Jul;49(3):357-61. Indian J Pathol Microbiol. 2006. PMID: 17001884 - Hepatitis C virus in chronic liver disease and hepatocellular carcinoma in Taiwan.
Chen DS. Chen DS. Princess Takamatsu Symp. 1995;25:27-32. Princess Takamatsu Symp. 1995. PMID: 8875606 Review. - Clinical outcomes after transfusion-associated hepatitis C.
Tong MJ, el-Farra NS, Reikes AR, Co RL. Tong MJ, et al. N Engl J Med. 1995 Jun 1;332(22):1463-6. doi: 10.1056/NEJM199506013322202. N Engl J Med. 1995. PMID: 7739682 - Hepatitis B and C viruses in hepatitis B surface antigen negative hepatocellular carcinoma patients.
Bréchot C, Minami M, De Mitri S, Paterlini P. Bréchot C, et al. Princess Takamatsu Symp. 1995;25:199-209. Princess Takamatsu Symp. 1995. PMID: 8875625 Review.
Cited by
- Is hepatitis C virus carcinogenic?
Lemon SM, McGivern DR. Lemon SM, et al. Gastroenterology. 2012 May;142(6):1274-8. doi: 10.1053/j.gastro.2012.01.045. Gastroenterology. 2012. PMID: 22537433 Free PMC article. - Histologic study of chronic active hepatitis C; comparison with chronic active hepatitis B.
Hahm KB, Chon CY, Kim WH, Han KH, Chung JB, Lee SI, Moon YM, Kang JK, Park IS, Choi HJ, et al. Hahm KB, et al. Korean J Intern Med. 1992 Jul;7(2):102-10. doi: 10.3904/kjim.1992.7.2.102. Korean J Intern Med. 1992. PMID: 1306071 Free PMC article. - Prevalence of antibody against non-A, non-B hepatitis virus in Japanese patients with hepatocellular carcinoma.
Ohkoshi S, Kojima H, Tawaraya H, Miyajima T, Kamimura T, Asakura H, Satoh A, Hirose S, Hijikata M, Kato N, et al. Ohkoshi S, et al. Jpn J Cancer Res. 1990 Jun-Jul;81(6-7):550-3. doi: 10.1111/j.1349-7006.1990.tb02605.x. Jpn J Cancer Res. 1990. PMID: 2169469 Free PMC article. - Inflammation and p53: A Tale of Two Stresses.
Gudkov AV, Gurova KV, Komarova EA. Gudkov AV, et al. Genes Cancer. 2011 Apr;2(4):503-16. doi: 10.1177/1947601911409747. Genes Cancer. 2011. PMID: 21779518 Free PMC article. - Cumulative risk of hepatocellular carcinoma in hepatitis C virus carriers: statistical estimations from cross-sectional data.
Tanaka H, Hiyama T, Tsukuma H, Fujimoto I, Yamano H, Okubo Y, Kitada A. Tanaka H, et al. Jpn J Cancer Res. 1994 May;85(5):485-90. doi: 10.1111/j.1349-7006.1994.tb02384.x. Jpn J Cancer Res. 1994. PMID: 8014106 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical